Investor Calendar is powered by PrecisionIR, the leading webcaster of official investor relations events, and offers free access to live and archived corporate communications
 
  Home     Calendar     Conferences     Roadshows     Forums     Alerts     Research     Support     Podcast  
  Sanuwave Health, Inc. (SNWV.OB) www.sanuwave.com
Sanuwave Health, Inc.

Enter your email address to receive alerts about this company
Help
July 20, 2010 - 12:00 PM Eastern
LHA Life Sciences & Med Tech Day 2010 Presentation


      More company presentations from
                    		 
 
Information contained in this webcast is current as of the date and time first presented. The use of pop-up blocking or firewall software may prevent you from accessing this webcast. Please temporarily disable any of these products you may have while attempting to access this event.
About The Company
SANUWAVE Health, Inc. (www.sanuwave.com) is an emerging regenerative medicine company focused on the development and commercialization of non-invasive, biological response activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. SANUWAVE’s portfolio of products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body’s normal healing processes and regeneration. SANUWAVE intends to apply its Pulsed Acoustic Cellular Expression (PACE™) technology in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions. Its lead product candidate for the global wound care market, dermaPACE™, is CE marked for treatment of the skin and subcutaneous soft tissue and is currently involved in an FDA-approved Investigational Device Exemption trial in the U.S. for the treatment of diabetic foot ulcers. SANUWAVE researches, designs, manufactures, markets and services its products worldwide and believes it has already demonstrated that this technology is safe and effective in stimulating healing in chronic conditions of the foot (plantar fasciitis) and the elbow (lateral epicondylitis) through its U.S. Class III PMA approved Ossatron® device, as well as stimulating bone and chronic tendonitis regeneration in the musculoskeletal environment through the utilization of its Ossatron® and Evotron™ devices in Europe.

Market Assistant
Earnings Data
Annual Report
Related Events (times are Eastern) Show times in :
Company NameTicker Date/TimeTypeAlertsAudioPodcastVideoSlidesAnnual
Report
Sanuwave Health, Inc. SNWV.OB  Jul 20, 2010 
@ 12:00pm 		LHA Life Sciences & Med Tech Day 2010 PresentationSignup for email alerts about this company's events and news         

Comments or questions? Click Here

Privacy Statement Terms and Conditions


©2000-2013 PrecisionIR. All rights reserved.
   
 

A part of PrecisionIR Group, www.PrecisionIR.com
601 Moorefield Park Drive, Richmond, VA 23236
145 Cannon Street, London, EC4N 5BQ, UK (Registered in England No 2394368)
Strandvägen 7A, 114 56 Stockholm, Sweden